KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unitedhealth (UNH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Unitedhealth (UNH) over the last 17 years, with Q3 2025 value amounting to $27.2 billion.

  • Unitedhealth's Cash & Equivalents fell 1601.85% to $27.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $27.2 billion, marking a year-over-year decrease of 1601.85%. This contributed to the annual value of $25.3 billion for FY2024, which is 45.23% down from last year.
  • As of Q3 2025, Unitedhealth's Cash & Equivalents stood at $27.2 billion, which was down 1601.85% from $28.6 billion recorded in Q2 2025.
  • Over the past 5 years, Unitedhealth's Cash & Equivalents peaked at $41.9 billion during Q1 2023, and registered a low of $266.0 million during Q4 2022.
  • Over the past 5 years, Unitedhealth's median Cash & Equivalents value was $26.3 billion (recorded in 2024), while the average stood at $26.3 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 8772.5% in 2022, then soared by 945902.26% in 2023.
  • Unitedhealth's Cash & Equivalents (Quarter) stood at $2.2 billion in 2021, then tumbled by 87.72% to $266.0 million in 2022, then surged by 9459.02% to $25.4 billion in 2023, then dropped by 0.45% to $25.3 billion in 2024, then rose by 7.5% to $27.2 billion in 2025.
  • Its Cash & Equivalents stands at $27.2 billion for Q3 2025, versus $28.6 billion for Q2 2025 and $30.7 billion for Q1 2025.